Vigamoks - an antimicrobial drug from the group of fluoroquinolones, used in ophthalmology.
Release form and composition
Make eye drops Vigamoks 0.5%. 1 ml of the drug contains 5 μg of moxifloxacin.
In dropper bottles of 3 or 5 ml.
Indications for use
According to the instructions, Vigamoks is intended for the treatment of bacterial conjunctivitis caused by microorganisms that are susceptible to the active component of the drug.
According to the instructions, Vigamoks is contraindicated in the following cases:
- Hypersensitivity to moxifloxacin or other quinolones;
- Children's age up to one year;
- Breastfeeding period.
Dosing and Administration
Vigamoks intended for local use.
Children over one year old and adults are buried in the affected eye with 3 drops of medication three times a day. As a rule, the patient's condition improves after 5 days after the start of the use of Vigamox, however, to avoid relapse, the medicine should be instilled within two or three days after the symptoms disappear.
If 5 days after the start of treatment, the patient's condition does not improve, it is recommended to consult a doctor for a more accurate diagnosis and selection of alternative treatment.
The duration of therapy depends on the severity of the condition and the bacteriological course of conjunctivitis.
The use of Vigamox can cause the following side effects:
- Local reactions: irritation in the eye, pain and itching, hyperemia of the eye and conjunctiva, dry eye syndrome, punctate keratitis, eyelid erythema, blurred vision, discomfort and foreign body in the eye, swelling of the eye, subconjunctival hemorrhage;
- Systemic reactions: dysgeusia, paresthesia, headache, discomfort in the nose, decrease in hemoglobin in the blood, foreign body sensation in the throat, pharyngolaryngeal pain, increased GGT and ALT, vomiting.
The development of allergic reactions requires the abolition of Vigamox.
Some patients taking systemic drugs of the quinolone series, including Vigamoks, experienced hypersensitivity reactions, sometimes even after a single use: loss of consciousness, collapse, shortness of breath, airway obstruction, skin rash, itching.
If an excessive amount of medicine gets into your eyes, rinse with water.
It is allowed to use Vigamox during pregnancy, however, only in cases when the expected benefit to the mother outweighs the potential risks to the fetus.
During breastfeeding, Vigamox is contraindicated, as its active ingredient passes into breast milk.
Since patients may experience a decrease in visual acuity and blurred vision during Vigamox treatment, it is necessary to carefully manage dangerous mechanisms that require high concentration of attention.
Structural analogues and drugs that have similar pharmacological effects are:
Terms and conditions of storage
According to the instructions, Vigamoks should be stored at a cool temperature, in a dry, dark and out of reach of children. The shelf life of the drug is 2 years.